Nuvama Wealth Management Ltd.
IPOs where Nuvama Wealth Management Ltd. acted as a book-running lead manager, with each issue’s size and listing outcome.
Track record on ipostation
ipostation's database lists Nuvama Wealth Management Ltd. as a book-running lead manager on 8 IPOs: all of them mainboard issues. Bidding dates recorded here run from Aug 2026 to Oct 2026, and 1 issue has no bidding date recorded yet. Of these, 4 have listed, 3 are between scheduling and listing and 1 is at the draft-filing (announced) stage. It shared every one of these mandates with at least one other lead manager.
Issue size is recorded for all 8 IPOs. They range from ₹475.48 Cr (Sahajanand Medical Technologies) to ₹22,562.71 Cr (NSE), with a median of ₹940.37 Cr. The 4 listed issues with a recorded size total ₹25,248.45 Cr; sizes for issues that have not listed are the amounts stated in their offer documents.
A listing-day change is recorded for 4 listed issues: 3 above and 1 below the issue price. The median change was +3.6%, from -2.1% (Manipal Payment and Identity Solutions) to +21.3% (Augmont Enterprises). These are past listing outcomes and say nothing about how a future issue will list.
Final overall subscription is recorded for all 6 issues whose bidding has closed. The median was 5.2x, ranging from 0.83x (Sahajanand Medical Technologies) to 111.18x (Augmont Enterprises).
Currently between scheduling and listing: Paras Healthcare, Sahajanand Medical Technologies and Fusion CX.
Nuvama Wealth Management Ltd. has worked alongside 21 other lead managers on these issues. The 5 most frequent, by number of shared issues:
- Motilal Oswal Investment Advisors Ltd. — 6 shared issues
- IIFL Capital Services Ltd. — 4 shared issues
- Axis Capital Ltd. — 3 shared issues
- JM Financial Ltd. — 3 shared issues
- Avendus Capital Pvt.Ltd. — 2 shared issues
IPOs with Nuvama Wealth Management Ltd. as lead manager
| IPO | Board | Status | Open date | Issue size | Price | Subscription | Listing gain |
|---|---|---|---|---|---|---|---|
| EAAA India Alternatives (Edelweiss) | Mainboard | Announced | — | ₹1,500 Cr | — | — | — |
| Paras Healthcare | Mainboard | Upcoming | 21 Oct 2026 | ₹1,450 Cr | ₹693 | — | — |
| Sahajanand Medical Technologies | Mainboard | Closed | 15 Oct 2026 | ₹475.48 Cr | ₹344 | 0.83x | — |
| Fusion CX | Mainboard | Closed | 14 Oct 2026 | ₹702 Cr | ₹289 | 4.68x | — |
| NSE | Mainboard | Listed | 17 Sept 2026 | ₹22,562.71 Cr | ₹1,785 | 5.71x | +0.8% |
| Manipal Payment and Identity Solutions | Mainboard | Listed | 9 Sept 2026 | ₹805 Cr | ₹339 | 1.42x | -2.1% |
| Kanohar Electricals | Mainboard | Listed | 8 Sept 2026 | ₹1,055.74 Cr | ₹632 | 90.59x | +6.3% |
| Augmont Enterprises | Mainboard | Listed | 21 Aug 2026 | ₹825 Cr | ₹788 | 111.18x | +21.3% |
Subscription is the final overall figure once bidding has closed; listing gain is the listing-day change against the issue price. “—” means not available.
Year by year
| Bidding year | IPOs | Mainboard | SME | Total issue size | Median listing gain |
|---|---|---|---|---|---|
| 2026 | 7 | 7 | 0 | ₹27,875.93 Cr | +3.6% (4 listed) |
| Not yet scheduled | 1 | 1 | 0 | ₹1,500 Cr | — |
What a book-running lead manager does
Under Regulation 23 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, an issuer must appoint one or more SEBI-registered merchant bankers, at least one of whom is a lead manager to the issue. When more than one merchant banker manages an issue, each one’s responsibilities for disclosures, allotment, refunds and underwriting are fixed in advance and set out in the draft offer document and the offer document.